← FDA Drug Approvals (Drugs@FDA)

KRYSTEXXA

BLA · Biologics License Application · Sponsor: HORIZON PHARMA · Approved 2010-09-14

Drug application

FDA Application #
BLA125293
Application type
Biologics License Application
Brand name
KRYSTEXXA
Generic name
PEGLOTICASE
Active ingredients
PEGLOTICASE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
HORIZON PHARMA
Manufacturer
Horizon Therapeutics USA, Inc.
First approval
2010-09-14

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown